BiotechTube

PLF with NeoFuse + PLF with NeoFuse + PLF with NeoFuse

Phase 1/2Withdrawn
0 watching 0 views this week💤 Quiet
36
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Degenerative Disc Disease

Conditions

Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis

Trial Timeline

Nov 1, 2008 → Nov 1, 2011

NCT ID
NCT00810212

About PLF with NeoFuse + PLF with NeoFuse + PLF with NeoFuse

PLF with NeoFuse + PLF with NeoFuse + PLF with NeoFuse is a phase 1/2 stage product being developed by Mesoblast for Degenerative Disc Disease. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00810212. Target conditions include Degenerative Disc Disease, Degenerative Spondylolisthesis, Spinal Stenosis.

Hype Score Breakdown

Clinical
13
Activity
8
Company
5
Novelty
4
Community
3

Clinical Trials (1)

NCT IDPhaseStatus
NCT00810212Phase 1/2Withdrawn

Competing Products

17 competing products in Degenerative Disc Disease

See all competitors
ProductCompanyStageHype Score
LatozinemabAlectorPhase 3
69
YH14618 + YH14618 + YH14618 + PlaceboYuhanPhase 1/2
41
Placebo + YH14618YuhanPhase 2
52
Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial CellsAstellas PharmaPhase 1/2
41
ONO-2808 + PlaceboOno PharmaceuticalPhase 1
33
Pimavanserin + PlaceboAcadia PharmaceuticalsPhase 3
72
PimavanserinAcadia PharmaceuticalsApproved
80
PimavanserinAcadia PharmaceuticalsPhase 3
72
Lumbar Interbody Fusion with Autograft + Lumbar Interbody Fusion with NeoFuse + Lumbar Interbody Fusion with NeoFuseMesoblastPhase 2
47
NeoFuseMesoblastPhase 2
47
Rexlemestrocel-L + HA mixture + SalineMesoblastPhase 3
72
Single Dose MPCs Injection + Single Dose MPCs InjectionMesoblastPhase 2
47
Rexlemestrocel-L + Rexlemestrocel-L + HA Mixture + PlaceboMesoblastPhase 3
72
NeoFuseMesoblastPhase 1/2
36
NeoFuseMesoblastPhase 1/2
36
Use iliac bone graft + use bone morphogenetic protein + use bone derived allograft MSCs + Use adipose tissue derived MSCs + Use amnion/placental derived MSCsBrain BiotechPhase 2/3
57
Blood sampling, skin biopsy, excreta sampling, lumbar punctureBrain BiotechPre-clinical
15

Other Products from Mesoblast

Remestemcel-L + PlaceboPhase 3
72
Remestemcel-LPhase 3
72
Rexlemestrocel-L + HA mixture + SalinePhase 3
72
Infusion of one MPC expanded cord unit and one unexpanded cord unit + Infusion of two unexpanded cord blood units.Phase 3
72
Prochymal® + Placebo + Standard of Care for GVHDPhase 3
72